Free Trial

Incannex Healthcare (IXHL) Short Interest Ratio & Short Volume

Incannex Healthcare logo
$1.93 +0.08 (+4.32%)
As of 01/17/2025 03:59 PM Eastern

Incannex Healthcare Short Interest Data

Incannex Healthcare (IXHL) has a short interest of 62,400 shares, representing 0.48% of the float (the number of shares available for trading by the public). This marks a 34.19% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.0, indicating that it would take 2.0 days of the average trading volume of 20,950 shares to cover all short positions.

Current Short Interest
62,400 shares
Previous Short Interest
46,500 shares
Change Vs. Previous Month
+34.19%
Dollar Volume Sold Short
$132,288.00
Short Interest Ratio
2.0 Days to Cover
Last Record Date
December 31, 2024
Outstanding Shares
17,640,000 shares
Float Size
13,100,000 shares
Short Percent of Float
0.48%
Today's Trading Volume
20,086 shares
Average Trading Volume
20,950 shares
Today's Volume Vs. Average
96%
Short Selling Incannex Healthcare?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Incannex Healthcare and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

IXHL Short Interest Over Time

IXHL Days to Cover Over Time

IXHL Percentage of Float Shorted Over Time

Incannex Healthcare Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
12/31/202462,400 shares $132,288.00 +34.2%0.5%2 $2.12
12/15/202446,500 shares $86,490.00 +67.9%0.4%1.6 $1.86
11/30/202427,700 shares $49,306.00 +0.7%0.2%1 $1.78
11/15/202427,500 shares $55,000.00 -44.1%0.2%1 $2.00
10/31/202449,200 shares $111,684.00 -29.8%0.4%1.7 $2.27
10/15/202470,100 shares $125,479.00 -27.1%0.5%2.2 $1.79
9/30/202496,100 shares $191,239.00 -20.3%0.7%3.5 $1.99
9/15/2024120,600 shares $196,578.00 +6.4%0.9%4 $1.63
8/31/2024113,400 shares $199,584.00 +72.3%0.9%3.6 $1.76
8/15/202465,800 shares $117,782.00 +69.2%0.5%2 $1.79
7/31/202438,900 shares $74,299.00 +177.9%0.3%1.2 $1.91
7/15/202414,000 shares $37,660.00 +100.0%0.1%0.5 $2.69
6/30/20247,000 shares $20,580.00 -69.0%0.1%0.3 $2.94
6/15/202422,600 shares $75,032.00 -32.9%0.2%0.8 $3.32
5/31/202433,700 shares $95,371.00 -24.6%0.3%0.6 $2.83
5/15/202444,700 shares $129,630.00 -18.6%0.4%0.2 $2.90
4/30/202454,900 shares $158,661.00 +31.3%0.5%0.2 $2.89
4/15/202441,800 shares $110,770.00 -53.1%0.4%0.1 $2.65
3/31/202489,200 shares $320,228.00 -57.2%0.8%0.3 $3.59
3/15/2024208,200 shares $649,584.00 +113.1%1.8%0.7 $3.12
2/29/202497,700 shares $530,511.00 +0.5%0.9%0.3 $5.43
2/15/202497,200 shares $427,680.00 +57.3%0.6%1 $4.40
1/31/202461,800 shares $212,592.00 -22.8%0.4%0.9 $3.44
1/15/202480,000 shares $344,000.00 -14.5%0.5%1.2 $4.30
12/31/202393,600 shares $434,304.00 +107.5%0.0%1.4 $4.64
12/15/202345,100 shares $173,184.00 +705.4%0.0%0.7 $3.84
11/30/20235,600 shares $44,744.00 -9.7%N/A0.1 $7.99
11/15/20236,200 shares $6,005.32 -17.3%N/A0.6 $0.97
10/31/20237,500 shares $7,875.00 -68.5%N/A0.8 $1.05
10/15/202323,800 shares $23,800.00 -21.7%N/A1.8 $1.00
9/30/202330,400 shares $34,552.64 -11.1%N/A2.2 $1.14
9/15/202334,200 shares $48,051.00 -9.8%N/A0.3 $1.41
8/31/202337,900 shares $54,955.00 -13.9%N/A0.3 $1.45
8/15/202344,000 shares $69,080.00 -4.4%N/A0.4 $1.57
7/31/202346,000 shares $83,260.00 -25.5%N/A0.4 $1.81
7/15/202361,700 shares $120,932.00 +174.2%N/A0.5 $1.96
6/30/202322,500 shares $41,287.50 +4.2%N/A0.2 $1.84
6/15/202321,600 shares $41,364.00 +16.8%N/A5.5 $1.92
5/31/202318,500 shares $35,150.00 -3.1%N/A3.4 $1.90
5/15/202319,100 shares $37,699.58 +27.3%N/A3.2 $1.97
Bill Gates’ is about to mint millionaires (again) with Stargate. (Ad)

This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.
4/30/202315,000 shares $32,370.00 +105.5%N/A2.2 $2.16
4/15/20237,300 shares $15,403.00 -4.0%N/A1 $2.11
3/31/20237,600 shares $16,758.00 -48.3%N/A1.1 $2.21
3/15/202314,700 shares $35,069.79 -15.0%N/A2 $2.39
2/28/202317,300 shares $44,115.00 +76.5%N/A2.5 $2.55
2/15/20239,800 shares $29,400.00 -16.2%N/A1.3 $3.00
1/31/202311,700 shares $37,819.08 +6.4%N/A1.6 $3.23
1/15/202311,000 shares $37,455.00 -24.7%N/A1.6 $3.41
12/30/202214,600 shares $40,880.00 +25.9%N/A1.7 $2.80
12/15/202211,600 shares $39,092.00 -12.1%N/A1.3 $3.37
11/30/202213,200 shares $53,460.00 +43.5%N/A1.3 $4.05
11/15/20229,200 shares $37,352.00 +39.4%N/A0.9 $4.06
10/31/20226,600 shares $26,136.00 -56.6%N/A0.7 $3.96
10/15/202215,200 shares $65,208.00 -0.7%N/A1.3 $4.29
9/30/202215,300 shares $66,402.00 -5.0%N/A1.3 $4.34
9/15/202216,100 shares $82,110.00 -34.3%N/A1.3 $5.10
8/31/202224,500 shares $103,390.00 -26.0%N/A1.8 $4.22
8/15/202233,100 shares $162,521.00 -8.3%N/A2.5 $4.91
7/31/202236,100 shares $125,989.00 -18.7%N/A2.3 $3.49
7/15/202244,400 shares $152,292.00 No ChangeN/A2.4 $3.43

IXHL Short Interest - Frequently Asked Questions

What is Incannex Healthcare's current short interest?

Short interest is the volume of Incannex Healthcare shares that have been sold short but have not yet been closed out or covered. As of December 31st, investors have sold 62,400 shares of IXHL short. 0.48% of Incannex Healthcare's shares are currently sold short. Learn More on Incannex Healthcare's current short interest.

What is a good short interest ratio for Incannex Healthcare?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IXHL shares currently have a short interest ratio of 2.0. Learn More on Incannex Healthcare's short interest ratio.

What is a good short interest percentage for Incannex Healthcare?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.48% of Incannex Healthcare's floating shares are currently sold short.

Is Incannex Healthcare's short interest increasing or decreasing?

Incannex Healthcare saw a increase in short interest in December. As of December 31st, there was short interest totaling 62,400 shares, an increase of 34.2% from the previous total of 46,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Incannex Healthcare's float size?

Incannex Healthcare currently has issued a total of 17,640,000 shares. Some of Incannex Healthcare's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Incannex Healthcare currently has a public float of 13,100,000 shares.

How does Incannex Healthcare's short interest compare to its competitors?

0.48% of Incannex Healthcare's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Incannex Healthcare: Instil Bio, Inc. (19.28%), Aligos Therapeutics, Inc. (22.37%), Tenaya Therapeutics, Inc. (18.92%), Leap Therapeutics, Inc. (7.67%), XBiotech Inc. (3.90%), Atossa Therapeutics, Inc. (6.81%), Alto Neuroscience, Inc. (17.34%), Protara Therapeutics, Inc. (24.72%), Inventiva S.A. (0.67%), Nuvectis Pharma, Inc. (17.15%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks.

What does it mean to sell short Incannex Healthcare stock?

Short selling IXHL is an investing strategy that aims to generate trading profit from Incannex Healthcare as its price is falling. IXHL shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Incannex Healthcare?

A short squeeze for Incannex Healthcare occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IXHL, which in turn drives the price of the stock up even further.

How often is Incannex Healthcare's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IXHL, twice per month. The most recent reporting period available is December, 31 2024.




This page (NASDAQ:IXHL) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners